Here is more discussion of Intermittent ADT and Firmagon vs Lupron others might find interesting.
grandroundsinurology.com/mi...
I'll say on the front end it involves discussion of mouse studies which I know is controversial, but hopefully there is some meaningful data gleaned from mouse studies or they'd stop doing them, wouldn't they?
Anyway, I found this information very interesting.
Here is one nugget from the piece:
"While Dr. Klotz thought this analysis would disprove Morote’s conclusion, in actuality, the results of the analysis vindicated Morote’s observation that that lower nadir testosterone in the first year of ADT correlates with a low time to CRPC and improved cause-specific survival."